Ocular Therapeutix, Inc.

OCUL

$10.64

-2.39%

N/A-$0.26

Healthcare

Biotechnology

NASDAQ

Active Trading

Ocular Therapeutix, Inc. is a biopharmaceutical company specializing in the creation, advancement, and commercialization of ophthalmic treatments. Their innovative approach leverages a ...

Insider Transactions of OCUL

Acquisitions (A)

Since Jun 10, 2026

Disposals (D)

Since Jun 10, 2026

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Insider Trading Snapshot

Date	Executive	Title	Security	Side	Shares	Price
Aug 31, 2026	Notman Donald	officer: Chief Operating Officer	Common Stock	D	1,099	$10.24
Aug 25, 2026	Dugel Pravin	director, officer: See Remarks	Common Stock	A	50,092	—
Aug 25, 2026	Dugel Pravin	director, officer: See Remarks	Common Stock	D	50,092	—
Aug 24, 2026	Kaiser Peter	officer: Chief Development Officer	Common Stock	D	3,035	$10.77
Aug 24, 2026	Nayak Sanjay	officer: Chief Strategy Officer	Common Stock	D	1,897	$10.78

Insider Trading Snapshot

Acquisitions (A)

Disposals (D)

Total Shares Bought

114,184

Total Shares Sold

131,160

Monthly Insider Activity

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Transactions by Title - Shares

X-axis: shares, sorted by total shares desc

Transactions by Title - Counts

X-axis: counts, sorted by A+D counts desc

Key People: Buy/Sell Activity and Price

Dugel Pravin

director, officer: See Remarks • 5 txns

Notman Donald

officer: Chief Operating Officer • 1 txns

Kaiser Peter

officer: Chief Development Officer • 1 txns

Nayak Sanjay

officer: Chief Strategy Officer • 1 txns

Transactions Table

Date	Executive	Title	Security	Side	Shares	Price	Value
Aug 31, 2026	Notman Donald	officer: Chief Operating Officer	Common Stock	D	1,099	$10.24	$11,253.76
Aug 25, 2026	Dugel Pravin	director, officer: See Remarks	Common Stock	A	50,092	—	—
Aug 25, 2026	Dugel Pravin	director, officer: See Remarks	Common Stock	D	50,092	—	—
Aug 24, 2026	Kaiser Peter	officer: Chief Development Officer	Common Stock	D	3,035	$10.77	$32,686.95
Aug 24, 2026	Nayak Sanjay	officer: Chief Strategy Officer	Common Stock	D	1,897	$10.78	$20,449.66
Aug 24, 2026	Heier Jeffrey S.	officer: Chief Scientific Officer	Common Stock	D	3,296	$10.78	$35,530.88
Aug 24, 2026	Dugel Pravin	director, officer: See Remarks	Common Stock	D	21,649	$10.77	$233,159.73
Jun 16, 2026	Dugel Pravin	director, officer: See Remarks	Common Stock	D	50,092	—	—
Jun 16, 2026	Dugel Pravin	director, officer: See Remarks	Common Stock	A	50,092	—	—
Jun 10, 2026	Warden Charles M	director	Common Stock	A	14,000	—	—

Upstream

Dexamethasone API Suppliers (Multiple Qualified Generic Suppliers)Axitinib API SuppliersHydrogel Polymer Raw Material Suppliers (PEG/PLGA-based polymers)Sterile Packaging & Medical Device Component SuppliersThird-Party CMOs for R&D Product Candidates

Downstream

Cencora (formerly AmerisourceBergen) — via Besse MedicalNYSE:COR Cardinal Health — via Cardinal Specialty Pharma DistributionNYSE:CAH McKesson Corporation — via McKesson Medical-Surgical & McKesson Plasma & BiologicsNYSE:MCK Henry Schein, Inc.NASDAQ:HSICFFF EnterprisesMetro MedicalAffaMed Therapeutics Limited

Proxies

EyePoint Pharmaceuticals, Inc.NASDAQ:EYPT Glaukos CorporationNYSE:GKOS Tarsus Pharmaceuticals, Inc.NASDAQ:TARS

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

No matching stocks found

Ocular Therapeutix, Inc.

Insider Transactions of OCUL

Insider Trading Snapshot

Monthly Insider Activity

Transactions by Title - Shares

Transactions by Title - Counts

Key People: Buy/Sell Activity and Price

Transactions Table

Supply Chain of OCUL

Upstream

Downstream

Proxies

Insider Transactions of OCUL

Insider Trading Snapshot

Monthly Insider Activity

Transactions by Title - Shares

Transactions by Title - Counts

Key People: Buy/Sell Activity and Price

Transactions Table

Supply Chain of OCUL

Upstream

Downstream

Proxies